LAWRENCE, Mass.—NxStage Medical, Inc., today announced the latest interim findings from its FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study, which found daily home hemodialysis (HHD) treatments with the NxStage System One are associated with long-term improvements in various physical and mental quality of life measures.

These interim FREEDOM Study results, "At-Home Short Daily Hemodialysis Improves the Long-Term Health-Related Quality of Life," were published online on Kidney International's website in advance of its release in print.

NxStage's FREEDOM Study is the largest prospective study of frequent HHD to date. The FREEDOM Study reported improvements in several quality of life measures in end stage renal disease (ESRD) patients at 12 months of follow-up, including:

...